Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance

Archives of General Psychiatry

Volumn 60, Issue 2, 2003, Pages 198-203

  Mulsant, Benoit H ^a,b,e   Pollock, Bruce G ^a   Kirshner, Margaret ^a   Shen, Changyu ^c   Dodge, Hiroko ^c   Ganguli, Mary ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE;

AGE; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD SAMPLING; COGNITION; COGNITIVE DEFECT; COMMUNITY; CONTROLLED STUDY; DELIRIUM; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MINI MENTAL STATE EXAMINATION; RADIORECEPTOR ASSAY; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LOGISTIC MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; RADIOLIGAND ASSAY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0037315114     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.2.198     Document Type: Article

References (54)

1. Granacher R, Baldessarini RJ. Physostigmine: its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry. 1975; 32:375-380.
2. Greenbalt DJ, Shader RI. Drug therapy: anticholinergics. N Engl J Med. 1973; 288:1215-1219.
3. Pedigo AM. Case of atropia poisoning successfully treated with amyl nitrite, with remarks on treatment. Va Med Mon. 1888;15:81-87.
4. Miller PS, Richardson JS, Jyu CA, Lemay JS, Hiscock M, Keegan DL. Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. Am J Psychiatry. 1988;145:342-345.
5. Molchan SE, Martinez AJ, Hill JL, Weingartner HJ, Thompson K, Vitiello B, Sunderland T. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res Rev. 1992;17:215-226.
6. Sunderland T, Tariot P, Cohen RM, Weingartner H, Mueller EA, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and agematched controls. Arch Gen Psychiatry. 1987;44:418-426.
7. Tariot PN, Patel SV, Cox C, Henderson RE. Age-related decline in central cholinergic function demonstrated with scopolamine. Psychopharmacology. 1996; 125:50-56.
8. Blazer DG, Federspiel CF, Ray WA, Schaffner W. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol. 1983;38:31-35.
9. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993;3:335-348.
10. Tollefson G, Montague-Clouse J, Lancaster SP. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci. 1991;3:314-319.
11. Tune LE. Serum anticholinergic activity levels and delirium in the elderly. Sem Clin Neuropsychiatry. 2000;5:149-153.
12. Tune L, Coyle JT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry. 1980;37:293-297.
13. Tune L, Coyle JT. Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics. Psychopharmacology. 1981;75:9-15.
14. Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry. 1992;149:1393-1394.
15. Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP. Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci. 1990; 240:28-33.
16. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord. 1999; 10:342-344.
17. Mach JR Jr, Dysken MW, Kuskowski M, Richelson E, Holden L, Jilk KM. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc. 1995;43:491-495.
18. Chengappa KNR, Pollock BG, Parepally H, Levine J, Kirshner M, Brar J, Zoretich R. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J Clin Psychopharmacol. 2000;20:311-316.
19. Katz IR, Greenberg WH, Barr GA, Garbarino C, Buckley P, Smith D. Screening for cognitive toxicity of anticholinergic drugs. J Clin Psychiatry. 1985;46:323-326.
20. Perlick D, Stastny P, Katz I, Mayer M, Mattis S. Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry. 1986;143:230-232.
21. Strauss ME, Lew MF, Coyle JT, Tune LE. Psychopharmacologic and clinical correlates of attention in chronic schizophrenia. Am J Psychiatry. 1985;142:497-499.
22. Strauss ME, Lew MF, Coyle JT, Tune LE. Effects of anticholinergic medication on memory in schizophrenia. Schizophr Res. 1990;3:127-129.
23. Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone. J Clin Psychiatry. 1998;59:184-188.
24. Tracy JI, Monaco C, Giovannetti T, Abraham G, Josiassen RC. Anticholinergicity and cognitive processing in chronic schizophrenia. Biol Psychol. 2001;56: 1-22.
25. Tune LE, Strauss ME, Lew MF, Breitlinger E, Coyle JT. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry. 1982;139:1460-1462.
26. Flacker JM, Lipsitz LA. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol Med Sci. 1999;54:M12-M16.
27. Flacker JM, Cummings V, Mach JR Jr, Bettin K, Kiely DK, Wei J. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry. 1998;6:31-41.
28. Golinger RC, Peet T, Tune LE. Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry. 1987;144:1218-1220.
29. Mondimore FM, Damlouji N, Folstein MF, Tune L. Post-ECT confusional states associated with elevated serum anticholinergic levels. Am J Psychiatry. 1983; 140:930-931.
30. Mussi C, Ferrari R, Ascari S, Salvioli G. Importance of serum anticholinergic activity in the assessment of elderly patients with delirium. J Geriatr Psychiatry Neurol. 1999;12:82-86.
31. Nebes RD, Pollock BG, Mulsant BH, Kirshner MA, Halligan E, Zmuda M, Reynolds CF 3rd. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol Bull. 1997; 33:715-720.
32. Rovner BW, David A, Lucas-Blaustein MJ, Conklin B, Filipp L, Tune L. Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry. 1988;145:107-109.
33. Tune LE, Holland A, Folstein MF, Damlouji N, Gardner TJ, Coyle JT. Association of postoperative delirium with raised serum level of anticholinergic drugs. Lancet. 1981;2:651-652.
34. Ganguli M, Ratcliff G, Huff FJ, Belle S, Kancel MJ, Fischer L, Seaberg E, Kuller LH. Effects of age, gender, and education on cognitive tests in a rural elderly sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology. 1991;10:42-52.
35. Ganguli M, Seaberg E, Belle S, Fischer L, Kuller LH. Cognitive impairment and the use of health services in an elderly rural population: the MoVIES project: Monongahela Valley Independent Elders Survey. J Am Geriatr Soc. 1993;41:1065-1070.
36. Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES project. Neurology. 2000;54:1109-1116.
37. Gangull M, Lytle ME, Reynolds MD, Dodge HH. Random versus volunteer selection for a community-based study. J Gerontol Med Sci. 1998;53:M39-M46.
38. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
39. Lassila HC, Stoehr GP, Ganguli M, Seaberg EC, Gilby JE, Belle SH, Echement DA. Use of prescription medications in an elderly rural population: the MoVIES project. Ann Pharmacother. 1996;30:589-595.
40. Stoehr GP, Ganguli M, Seaberg EC, Echement DA, Belle S. Over-the-counter medication use in an older rural community: the MoVIES project. J Am Geriatr Soc. 1997;45:158-165.
41. Pollock BG, Mulsant BH, Nebes R, Kirshner M, Begley A, Mazumdar S, Reynolds CF. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry. 1998;155:1110-1112.
42. Mulsant BH, Sweet RA, Rifai AH, Pasternak RE, McEachran A, Zubenko GS. The use of the Hamilton Rating Scale for Depression in elderly patients with cognitive impairment and physical illness. Am J Geriatr Psychiatry. 1994;2:220-229.
43. Mulsant BH, Ganguli M, Seaberg EC. The relationship between self-rated health and depressive symptoms in an epidemiological sample of community-dwelling older adults. J Am Geriatr Soc. 1997;45:954-958.
44. Basu R, Dodge H, Ganguli M. Patterns of sedative-hypnotic use of diphenhydramine in a rural older adult community-based cohort. Am J Geriatr Psychiatry. In press.
45. 12 in elderly patients with progressive dementia. Am J Geriatr Psychiatry. 2002;10: 321-327.
46. Flacker JM, Wei JY. Endogenous anticholinergic substances may exist during acute illness in elderly medical patients. J Gerontol A Biol Sci. 2001;56:M353-M355.
47. Francis J. A half-century of delirium research: time to close the gap. J Am Geriatr Soc. 1995;43:585-586.
48. Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161:1099-1105.
49. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med. 2002; 161:2091-2097.
50. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.
51. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292-296.
52. Pollock BG. Geriatric psychiatry: psychopharmacology: general principles. In: Saddock BJ, Saddock VA, eds. Kaplan & Saddock's Comprehensive Textbook of Psychiatry. Baltimore, Md: Williams & Wilkins; 2000:3086-3090.
53. van Eijk ME, Avorn J, Porsius AJ, de Boer A. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ. 2001;322:654-657.
54. Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D'Angelo K. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc. 1998;46:8-13.